About the Advanced Regenerative Manufacturing Institute

Our mission is to advance the bioeconomy of the United States. The Institute’s work will positively impact not only manufacturing but also healthcare and education and workforce development for the nation.

Manufacturing scalability, process and partnership.

There are 400,000 people worldwide right now on waiting lists for organs. What if we could create lungs, livers or corneas at scale? It would be unprecedented.

Our goal is to move highly specialized regenerative medicine – engineering or regenerating human cells, tissues and organs – from lab to production to cure diseases and improve quality of life.

ARMI’s Leadership Team

DEAN KAMEN

Executive Director & Chairman of the Board, ARMI

Maureen Toohey

Deputy Executive Director & Secretary of the Board

Thomas Bollenbach, Ph.D.

Chief Technology Officer

Jim Scott

Chief Administrative Officer

Jennifer MacDonald, M.D.

Chief Operating Officer

News Highlights

Events

JDRF TypeOneNation Summit Manchester

ARMI | BioFabUSA 150 Dow Street, Manchester, NH, United States

The TypeOneNation Summit is an educational and networking opportunity for all those impacted by type 1 diabetes (T1D).

McLane Middleton’s “What’s Her Story”

McLane Middleton 900 Elm Street, Manchester, United States

Julie Lenzer, Chief Innovation Officer at the Advanced Regenerative Manufacturing Institute (ARMI | BioFabUSA), will sit down with McLane Middleton attorney Linda Johnson.

BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

Technology

ARMI

Initiatives

Learn more about work underway to build the biofabrication ecosystem and accelerate the science of regenerative medicine.